{"id":"hiv-antiretroviral-therapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Lipodystrophy"},{"rate":null,"effect":"Hepatotoxicity"},{"rate":null,"effect":"Peripheral neuropathy"}]},"_chembl":{"chemblId":"CHEMBL3672477","moleculeType":"Small molecule","molecularWeight":"317.28"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"HIV antiretroviral therapy typically combines drugs from different classes (such as nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, and integrase inhibitors) that target distinct viral enzymes and processes. This combination approach, known as highly active antiretroviral therapy (HAART), suppresses viral replication, reduces viral load to undetectable levels, and allows immune system recovery. The multi-drug regimen also reduces the likelihood of developing drug-resistant viral strains.","oneSentence":"HIV antiretroviral therapy works by inhibiting viral replication through multiple mechanisms targeting different stages of the HIV life cycle.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:44:39.872Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"HIV-1 infection"},{"name":"AIDS prevention and treatment"}]},"trialDetails":[{"nctId":"NCT07042945","phase":"PHASE1","title":"MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-07-09","conditions":"HIV Infection","enrollment":28},{"nctId":"NCT06819176","phase":"PHASE1","title":"Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-01-20","conditions":"Human Immunodeficiency Virus","enrollment":50},{"nctId":"NCT00326482","phase":"","title":"Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-07-31","conditions":"Liver Fibrosis, Steatohepatitis, Elevated Transaminases","enrollment":127},{"nctId":"NCT04304768","phase":"PHASE4","title":"Opioid, HIV and Immune System","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2020-11-18","conditions":"Immune Defect","enrollment":400},{"nctId":"NCT07402044","phase":"","title":"CABOTEGRAVIR/LENACAPAVIR DUAL LONG ACTING THERAPY (COHORT IMEA 074)","status":"NOT_YET_RECRUITING","sponsor":"Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba","startDate":"2026-03-15","conditions":"CABOTEGRAVIR, LENACAPAVIR","enrollment":50},{"nctId":"NCT05419024","phase":"PHASE2","title":"Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-01-09","conditions":"HIV","enrollment":50},{"nctId":"NCT05165810","phase":"NA","title":"Evaluation of Multiple Interventions to Improve HIV Treatment Outcomes Among People Who Inject Drugs in India","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-03-09","conditions":"HIV Infections","enrollment":800},{"nctId":"NCT00039689","phase":"","title":"Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2002-07-12","conditions":"HIV","enrollment":750},{"nctId":"NCT07053384","phase":"PHASE1","title":"A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2025-07-10","conditions":"HIV Infections","enrollment":107},{"nctId":"NCT07194902","phase":"NA","title":"HIV Self-testing for Partners of HIV-uninfected Postpartum Women","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-03-19","conditions":"HIV Self-testing, Male Partners of HIV-negative Postpartum Women, PrEP Uptake","enrollment":120},{"nctId":"NCT07062614","phase":"","title":"Exploration of the Variability of Exposure to Antiretroviral Treatment in Hair With a View to Validating Its Value as a Diagnostic Tool for Partial and/or Total Non-compliance With Treatment","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-07-03","conditions":"HIV (Human Immunodeficiency Virus)","enrollment":30},{"nctId":"NCT02016924","phase":"PHASE2, PHASE3","title":"Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2014-01-16","conditions":"Acquired Immune Deficiency Syndrome (AIDS), HIV Infections","enrollment":133},{"nctId":"NCT05994742","phase":"PHASE3","title":"An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Queen Mary University of London","startDate":"2024-07-15","conditions":"Severe Acute Malnutrition, HIV, Comorbidities and Coexisting Conditions","enrollment":674},{"nctId":"NCT04645693","phase":"","title":"The Impact of Oral Health in HIV Patients on Antiretroviral Therapy","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2021-02-24","conditions":"HIV, Periodontal Diseases, Caries","enrollment":227},{"nctId":"NCT06823596","phase":"NA","title":"The T Cell Activator of Cell Killing (\"TACK\") IT ON\" STUDY","status":"RECRUITING","sponsor":"University of Toronto","startDate":"2025-01-14","conditions":"Hiv","enrollment":26},{"nctId":"NCT07476339","phase":"PHASE4","title":"REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE: A Multi-Center, Single-Arm, Open-Label, Phase 4 Study Assessing the Safety and Efficacy of B/F/TAF in HIV-Positive Adults Returning to Care After Experiencing a Treatment Interruption of ≥12 Weeks","status":"NOT_YET_RECRUITING","sponsor":"CAN Community Health","startDate":"2026-03-23","conditions":"HIV -1 Infection, HIV (Human Immunodeficiency Virus), HIV","enrollment":200},{"nctId":"NCT05612178","phase":"PHASE1","title":"A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2023-07-26","conditions":"HIV-1","enrollment":105},{"nctId":"NCT06337032","phase":"PHASE4","title":"A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments","status":"RECRUITING","sponsor":"Gilead Sciences","startDate":"2024-08-27","conditions":"HIV-1-infection","enrollment":350},{"nctId":"NCT04860323","phase":"NA","title":"Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP Study","status":"COMPLETED","sponsor":"HIV Vaccine Trials Network","startDate":"2021-05-28","conditions":"HIV Infection","enrollment":13},{"nctId":"NCT05075967","phase":"NA","title":"Getting to Zero Among HHI MSM in the American South","status":"ENROLLING_BY_INVITATION","sponsor":"HIV Prevention Trials Network","startDate":"2025-12-10","conditions":"HIV Infections","enrollment":2700},{"nctId":"NCT07466836","phase":"NA","title":"The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV","status":"NOT_YET_RECRUITING","sponsor":"Tyson Perez, DC, PhD","startDate":"2026-04","conditions":"Human Immunodeficiency Virus (HIV)","enrollment":40},{"nctId":"NCT05996471","phase":"PHASE2","title":"A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2023-08-17","conditions":"HIV Infections","enrollment":185},{"nctId":"NCT07376239","phase":"","title":"Quality of Life, Depression and Sexual Function in Men Living With HIV","status":"ENROLLING_BY_INVITATION","sponsor":"Kocaeli University","startDate":"2026-02-03","conditions":"HIV Infections","enrollment":100},{"nctId":"NCT06908083","phase":"PHASE1","title":"Immunologic and Virologic Parameters During Analytical Treatment Interruption Following Combination bNAb Therapy During Suppressive ART","status":"ENROLLING_BY_INVITATION","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-09-08","conditions":"HIV","enrollment":50},{"nctId":"NCT06468995","phase":"NA","title":"Antiviral Long Acting Drugs Landing in People Living With HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"IRCCS San Raffaele","startDate":"2024-12-02","conditions":"HIV, Antiviral Agents","enrollment":120},{"nctId":"NCT05917509","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2023-07-06","conditions":"HIV Infections","enrollment":171},{"nctId":"NCT00767312","phase":"","title":"Analysis of HIV-1 Replication During Antiretroviral Therapy","status":"ENROLLING_BY_INVITATION","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2008-11-17","conditions":"HIV","enrollment":70},{"nctId":"NCT06629753","phase":"NA","title":"Differentiated Service Delivery for Pregnant and Postpartum Women Living With HIV and Their Infants","status":"COMPLETED","sponsor":"Indiana University","startDate":"2024-09-13","conditions":"Hiv, Transmission Vertical, Viremia","enrollment":278},{"nctId":"NCT07453303","phase":"","title":"Comprehensive Geriatric Assessment in Adults Aged 40 Years and Older Living With HIV","status":"NOT_YET_RECRUITING","sponsor":"Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital","startDate":"2026-03-02","conditions":"Frailty, Sarcopenia","enrollment":80},{"nctId":"NCT06139796","phase":"PHASE1, PHASE2","title":"Pharmacokinetics Safety and Acceptability of DRV/r for Children Living With HIV","status":"WITHDRAWN","sponsor":"PENTA Foundation","startDate":"2025-02-01","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT03133728","phase":"","title":"Diagnosis of HIV and Early Antiretroviral Therapy Initiation Among HIV-1 Infected Infants","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2019-05-30","conditions":"HIV Infections, Hiv","enrollment":1682},{"nctId":"NCT06680479","phase":"PHASE1","title":"Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-04-01","conditions":"HIV-1","enrollment":30},{"nctId":"NCT07342491","phase":"PHASE1","title":"Dasatinib for HIV-1 Reservoir Reduction","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-03-02","conditions":"HIV Infections","enrollment":14},{"nctId":"NCT07428330","phase":"NA","title":"Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV","status":"RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2026-02-03","conditions":"Cervix Cancer, HIV Infections, HPV Infection","enrollment":1600},{"nctId":"NCT07439562","phase":"NA","title":"Choice-Based Support for Adults Starting or Restarting Antiretroviral Therapy in Cape Town, South Africa","status":"NOT_YET_RECRUITING","sponsor":"University of Cape Town","startDate":"2026-02","conditions":"HIV Care Loss to Followup","enrollment":140},{"nctId":"NCT05398185","phase":"NA","title":"WiseApp for Spanish Speakers Living With HIV","status":"RECRUITING","sponsor":"Columbia University","startDate":"2023-03-01","conditions":"HIV Infections, Acquired Immune Deficiency Syndrome, Sexually Transmitted Diseases, Viral","enrollment":248},{"nctId":"NCT05866523","phase":"NA","title":"Teamwork Makes the Dream Work","status":"RECRUITING","sponsor":"Loma Linda University","startDate":"2023-10-16","conditions":"HIV Infections, Inpatient Facility Diagnoses","enrollment":250},{"nctId":"NCT07433387","phase":"PHASE1, PHASE2","title":"Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals","status":"RECRUITING","sponsor":"Shanxi Kangbao Biological Product Co., Ltd.","startDate":"2026-01-29","conditions":"HIV","enrollment":30},{"nctId":"NCT03133559","phase":"","title":"Mapping the Human HIV Chronobiome","status":"SUSPENDED","sponsor":"University of Pennsylvania","startDate":"2017-04-19","conditions":"Hiv, Healthy","enrollment":80},{"nctId":"NCT06252402","phase":"EARLY_PHASE1","title":"CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-12-19","conditions":"HIV-1","enrollment":15},{"nctId":"NCT05393193","phase":"PHASE4","title":"POC HIV Testing and Early DTG Use for Infants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Harvard School of Public Health (HSPH)","startDate":"2022-07-04","conditions":"HIV","enrollment":900},{"nctId":"NCT03848858","phase":"NA","title":"Efficacy of EMDR Therapy, as Compared to Treatment as Usual, in Reducing Clinical Symptoms in People With HIV","status":"COMPLETED","sponsor":"Parc de Salut Mar","startDate":"2019-02-01","conditions":"HIV/AIDS, Psychological Trauma, PTSD","enrollment":40},{"nctId":"NCT02369406","phase":"PHASE2, PHASE3","title":"Early Infant HIV Treatment in Botswana","status":"ACTIVE_NOT_RECRUITING","sponsor":"Harvard School of Public Health (HSPH)","startDate":"2015-05-04","conditions":"HIV, Pediatric AIDS","enrollment":67},{"nctId":"NCT07209267","phase":"PHASE2","title":"Baricitinib Curative Repression of HIV-1","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-03","conditions":"HIV Infection, HIV","enrollment":20},{"nctId":"NCT07215468","phase":"PHASE2","title":"HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study","status":"RECRUITING","sponsor":"TaiMed Biologics Inc.","startDate":"2025-12-16","conditions":"HIV -1 Infection","enrollment":75},{"nctId":"NCT04991402","phase":"","title":"Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir","status":"COMPLETED","sponsor":"Columbia University","startDate":"2021-09-21","conditions":"HIV, Obesity, Obesity, Infant","enrollment":1920},{"nctId":"NCT06488846","phase":"","title":"Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, San Francisco","startDate":"2026-02-16","conditions":"HIV Infections","enrollment":1000},{"nctId":"NCT03825523","phase":"NA","title":"Immediate ART in Subjects With Opportunistic Diseases","status":"COMPLETED","sponsor":"Gustavo Reyes-Teran","startDate":"2019-02-18","conditions":"HIV/AIDS, ANTIRETROVIRAL TREATMENT","enrollment":114},{"nctId":"NCT06027671","phase":"NA","title":"Structured Peer-delivered ART and Reentry Community Strategy","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-11-18","conditions":"Retention in Care","enrollment":400},{"nctId":"NCT05886621","phase":"NA","title":"Testing the Integrated mHealth App Intervention \"SiS-H\"","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2023-11-07","conditions":"Smoking Cessation","enrollment":66},{"nctId":"NCT07226128","phase":"NA","title":"The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV","status":"NOT_YET_RECRUITING","sponsor":"Indiana University","startDate":"2026-02-15","conditions":"HIV, Depression in Adults, Insulin Resistance","enrollment":150},{"nctId":"NCT06071767","phase":"PHASE1, PHASE2","title":"Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-04-01","conditions":"HIV-1-infection","enrollment":36},{"nctId":"NCT05136703","phase":"NA","title":"Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)","status":"RECRUITING","sponsor":"Florida International University","startDate":"2022-08-30","conditions":"Depression, HIV-1-infection, Inflammation","enrollment":150},{"nctId":"NCT06886971","phase":"NA","title":"Strategies to AchieVe Viral Suppression for Youth With HIV","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-11-10","conditions":"Human Immunodeficiency Virus (HIV) Infection","enrollment":288},{"nctId":"NCT06497504","phase":"PHASE2","title":"Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)","status":"ACTIVE_NOT_RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2024-09-17","conditions":"Hepatitis B","enrollment":157},{"nctId":"NCT06411223","phase":"PHASE2","title":"Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2024-08-01","conditions":"Hiv","enrollment":50},{"nctId":"NCT05208697","phase":"NA","title":"Tele-Harm Reduction","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2022-10-10","conditions":"IV Drug Usage, HIV Infections, Hepatitis C","enrollment":100},{"nctId":"NCT06394323","phase":"NA","title":"Supporting Oral Pre-exposure Prophylaxis Decision Making Among Pregnant Women in Lilongwe, Malawi","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2024-08-06","conditions":"HIV Prevention","enrollment":132},{"nctId":"NCT07377760","phase":"NA","title":"Adaptive Text Messaging and Non-Monetary Incentives to Sustain ART Adherence Among Adolescents Living With HIV in Ethiopia","status":"NOT_YET_RECRUITING","sponsor":"Arba Minch University","startDate":"2026-03-09","conditions":"Antiretroviral Therapy (ART) Adherence Among Adolescents Living With HIV","enrollment":327},{"nctId":"NCT04820933","phase":"EARLY_PHASE1","title":"Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-03-01","conditions":"HIV I Infection, Cardiovascular Risk Factor, Lipid Metabolism Disorders","enrollment":26},{"nctId":"NCT06375135","phase":"NA","title":"Efficacy of mHealth + e-Navigator Stepped Care Intervention for ART Adherence Among Latino Men With HIV","status":"RECRUITING","sponsor":"Florida International University","startDate":"2024-06-06","conditions":"ART Adherence","enrollment":250},{"nctId":"NCT06541028","phase":"NA","title":"Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART)","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-11-04","conditions":"Hiv, Drug Use","enrollment":135},{"nctId":"NCT04233879","phase":"PHASE3","title":"Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-28","conditions":"HIV-1 Infection","enrollment":599},{"nctId":"NCT03497676","phase":"PHASE1, PHASE2","title":"More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-04-03","conditions":"HIV Infections","enrollment":168},{"nctId":"NCT03059121","phase":"","title":"The Cleveland Cardiometabolic Cohort","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2016-09","conditions":"HIV, Lipodystrophy","enrollment":56},{"nctId":"NCT07370649","phase":"","title":"Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study","status":"NOT_YET_RECRUITING","sponsor":"Pomeranian Medical University Szczecin","startDate":"2026-02-01","conditions":"Human Immunodeficiency Virus (HIV)-1 Infection, HIV-1 Subtype A6 Infection, HIV-1 Subtype B Infection","enrollment":250},{"nctId":"NCT06814041","phase":"NA","title":"Pilot RCT and Interview Study on an HIV Chatbot in Nigeria","status":"ACTIVE_NOT_RECRUITING","sponsor":"Christoph Pimmer","startDate":"2025-04-14","conditions":"HIV","enrollment":314},{"nctId":"NCT04359186","phase":"NA","title":"SCOPE Analytic Treatment Interruption Protocol","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2020-10-15","conditions":"HIV/AIDS","enrollment":40},{"nctId":"NCT04985760","phase":"PHASE1","title":"Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy","status":"COMPLETED","sponsor":"Madhu Chhanda Choudhary","startDate":"2021-09-30","conditions":"HIV Infections","enrollment":32},{"nctId":"NCT04742387","phase":"","title":"Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-02-04","conditions":"Kaposi Sarcoma, KSHV Associated Multicentric Castleman Disease, Primary Effusion Lymphoma","enrollment":40},{"nctId":"NCT05281510","phase":"PHASE2","title":"Study of VRC07-523LS, CAP256V2LS, and Vesatolimod, in Early Antiretroviral-treated HIV-1 Clade C-infected Women","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2022-06-09","conditions":"HIV-1-infection","enrollment":20},{"nctId":"NCT06951542","phase":"NA","title":"HIV-Mental Illness Stigma Reduction and Outcomes in Malawi","status":"ENROLLING_BY_INVITATION","sponsor":"University of Pennsylvania","startDate":"2026-04-01","conditions":"Depression - Major Depressive Disorder, HIV, Health Condition Stigma","enrollment":200},{"nctId":"NCT03500172","phase":"NA","title":"HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2018-06-22","conditions":"HIV-1 Virologic Response","enrollment":1391},{"nctId":"NCT06006546","phase":"PHASE1","title":"The Study of Immunization in People Living With HIV Undergoing an ATI for Elicitation of VRC01-lineage Antibodies","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-01-03","conditions":"Chronic HIV Infection","enrollment":35},{"nctId":"NCT07336797","phase":"PHASE2","title":"Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy","status":"RECRUITING","sponsor":"Abdelrahman Mahmoud","startDate":"2025-09-01","conditions":"Metabolic Syndrome, Obesity & Overweight, HIV (Human Immunodeficiency Virus)","enrollment":66},{"nctId":"NCT01790373","phase":"NA","title":"Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2013-09-07","conditions":"HIV","enrollment":702},{"nctId":"NCT07329166","phase":"NA","title":"Reducing Mobility-associated Interruption in HIV Treatment in Malawi","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2025-12-18","conditions":"HIV","enrollment":400},{"nctId":"NCT01854775","phase":"PHASE2, PHASE3","title":"Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2013-05-06","conditions":"Acquired Immune Deficiency Syndrome (AIDS), HIV Infections","enrollment":129},{"nctId":"NCT05454839","phase":"","title":"Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston University","startDate":"2022-09-08","conditions":"HIV","enrollment":1098},{"nctId":"NCT05121064","phase":"NA","title":"Common Elements Treatment Approach HIV Alcohol Reduction Trial in Zambia","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2023-01-24","conditions":"HIV/AIDS, Alcohol-Related Disorders, Mental Illness","enrollment":680},{"nctId":"NCT05454852","phase":"","title":"Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in Zambia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston University","startDate":"2022-09-15","conditions":"HIV","enrollment":771},{"nctId":"NCT04951986","phase":"PHASE3","title":"Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cape Town","startDate":"2021-08-11","conditions":"Disseminated Tuberculosis, HIV","enrollment":732},{"nctId":"NCT04077047","phase":"NA","title":"Adolescents Living With HIV (ALWH): Social Networks, Adherence and Retention","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2022-09-01","conditions":"HIV/AIDS","enrollment":60},{"nctId":"NCT00006436","phase":"PHASE2","title":"EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2001-01-29","conditions":"Lymphoma, AIDS-related, Lymphoma, Large B-Cell, Diffuse","enrollment":68},{"nctId":"NCT04160455","phase":"","title":"Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.","status":"RECRUITING","sponsor":"Centre Hospitalier Régional d'Orléans","startDate":"2019-11-07","conditions":"Autophagy, Galectins, HIV Infections","enrollment":180},{"nctId":"NCT06834113","phase":"NA","title":"Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset","status":"RECRUITING","sponsor":"Centre Hospitalier Régional d'Orléans","startDate":"2025-01-24","conditions":"HIV I Infection, Injection Pain","enrollment":120},{"nctId":"NCT06358885","phase":"NA","title":"IGHID 12230 - An Implementation Trial of an Experiential Brief Alcohol Intervention for HIV Prevention","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2024-04-25","conditions":"HIV-1-infection, Unhealthy Alcohol Use","enrollment":3234},{"nctId":"NCT05947539","phase":"NA","title":"Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Intervention","status":"ENROLLING_BY_INVITATION","sponsor":"Arizona State University","startDate":"2023-07-01","conditions":"HIV-infection/Aids, Intimate Partner Violence, Domestic Violence","enrollment":80},{"nctId":"NCT03922269","phase":"","title":"Trans People Living With HIV Throughout Europe","status":"COMPLETED","sponsor":"Chelsea and Westminster NHS Foundation Trust","startDate":"2019-10-11","conditions":"HIV Infections, Gender Identity, Human Immunodeficiency Virus","enrollment":200},{"nctId":"NCT05187429","phase":"PHASE1, PHASE2","title":"Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy","status":"RECRUITING","sponsor":"University of Melbourne","startDate":"2023-01-24","conditions":"HIV I Infection","enrollment":42},{"nctId":"NCT03696160","phase":"PHASE3","title":"The Late Presenter Treatment Optimisation Study","status":"COMPLETED","sponsor":"NEAT ID Foundation","startDate":"2019-03-05","conditions":"HIV/AIDS","enrollment":447},{"nctId":"NCT04168008","phase":"NA","title":"A Peer-Led Intervention to Improve Postpartum Retention in HIV Care","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2020-03-03","conditions":"HIV/AIDS","enrollment":151},{"nctId":"NCT02591420","phase":"PHASE1","title":"Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-04","conditions":"HIV Infections","enrollment":24},{"nctId":"NCT02969915","phase":"NA","title":"Strategies to Improve the HIV Care Continuum Among Key Populations in India","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2017-10-30","conditions":"HIV Infections","enrollment":2314},{"nctId":"NCT05245292","phase":"PHASE1","title":"3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rockefeller University","startDate":"2022-12-07","conditions":"Human Immunodeficiency Virus","enrollment":28},{"nctId":"NCT05122767","phase":"PHASE1, PHASE2","title":"Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Aurum Institute NPC","startDate":"2023-05-24","conditions":"Tuberculosis, HIV","enrollment":92},{"nctId":"NCT07217379","phase":"PHASE1","title":"The DART DELIVER-02 Study","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2025-10-02","conditions":"HIV (Human Immunodeficiency Virus)","enrollment":24},{"nctId":"NCT07215325","phase":"PHASE4","title":"Got Doxy- 'Flipping the Script' on STI PEP","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-10-22","conditions":"Sexually Transmitted Infections (STI)","enrollment":200},{"nctId":"NCT06317051","phase":"PHASE3","title":"Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kirby Institute","startDate":"2024-12-16","conditions":"HIV Infections, Weight Gain","enrollment":300},{"nctId":"NCT05642481","phase":"","title":"Therapeutic Drug Monitoring to oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt to Breastfeed","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2023-03-01","conditions":"HIV-1-infection","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":465,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"HIV antiretroviral therapy","genericName":"HIV antiretroviral therapy","companyName":"French National Agency for Research on AIDS and Viral Hepatitis","companyId":"french-national-agency-for-research-on-aids-and-viral-hepatitis","modality":"Small molecule","firstApprovalDate":"","aiSummary":"HIV antiretroviral therapy works by inhibiting viral replication through multiple mechanisms targeting different stages of the HIV life cycle. Used for HIV-1 infection, AIDS prevention and treatment.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}